Competitors
Key Features |
PENTAX® Medical |
icSpeech® |
NasoCoustics |
Patient-Friendly |
✕ |
✕ |
✓ |
Adjustability |
✕ |
✕ |
✓ |
Wireless |
✕ |
✕ |
✓ |
Data Aggregation |
✕ |
✕ |
✓ |
Market Strategy
With over 200,000 ASHA-certified speech-language pathologists in the United States, NasoCoustics plans to initially target
this group of medical professionals. On the global scale, the nasometry market is projected to be valued at over
$330 million by 2030.
"The PENTAX Nasometer doesn't give better info than a subjective assessment"
-Jessie Johnson, CCC-SLP
"I do not have the physical space to designate an area for the Nasometer"
-Kelli Frisch, CCC-SLP
"I don't use a nasomety device because our clinic cannot afford one"
-Keegan Gallagher, CCC-SLP
"Nasometers are bulky and difficult to haul around our cleft palate clinic"
-Dr. Kimberly Meigh
"We could serve so many more patients if the device was more portable"
-Samantha Atkinson, CCC-SLP
Considering the opinions of key leaders in the speech-language pathologist field will allow NasoCoustics to gain credibility and visibility within this landscape. Working alongside such experts ensures our device addresses the failures in current nasometry devices.